Precision Dose Recalls Subpotent Carbamazepine Oral Suspension Unit Dose Cups
Precision Dose Inc. is recalling Carbamazepine Oral Suspension USP unit dose cups because they tested below the required potency specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically scoring 1 or 2 because it is unlikely to cause adverse health consequences. A score of 2 is assigned to reflect the subpotent nature of the drug, which is a minor labeling or quality error rather than a high-risk contamination.
Plain-English summary
Precision Dose Inc. is recalling Carbamazepine Oral Suspension USP, 100 mg/5 mL, 5 mL Unit Dose Cups (NDC 68094-301-59 and NDC 68094-301-62). The recall involves 801 cases of the product, which is distributed nationwide in the USA. The specific lot number is 500105, with an expiration date of 04/30/18.
The recall was initiated because the product yielded low out-of-specification results, indicating that the drug is subpotent. This means the medication may not contain the full amount of the active ingredient required to be effective.
Consumers and healthcare providers should stop using the affected product and contact their pharmacist or healthcare provider for guidance. The recall is classified as Class III by the FDA, which indicates that the violation is not likely to cause adverse health consequences.
The recalled product
- Product
- Carbamazepine Oral Suspension USP, 100 mg/5 mL, 5 mL Unit Dose Cups (NDC 68094-301-59), packaged in 10-count cups per tray, 3 trays per case containing a total of 5 mL x 30 Unit Dose Cups per case (NDC 68094-301-62), Rx only, Pkg: Precision Dose, Inc., S. Beloit, IL 61080.
- Manufacturer
- Precision Dose Inc.
- Category
- Drug — Anticonvulsant
- Hazard
- Affected units
- 801
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot number: 500105
- Exp 04/30/18
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Precision Dose Inc.
See all →- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateAcetaminophen Oral Suspension Recalled Due to Contaminated Raw Ingredient
FDA (Drugs) · 2021-11-17
- ModerateAcetaminophen Oral Suspension Recalled Due to Contaminated Raw Ingredient
FDA (Drugs) · 2021-11-17
- ModeratePrecision Dose Recalls Chlorhexidine Gluconate Oral Rinse Due to cGMP Deviations
FDA (Drugs) · 2021-01-20
- SeverePrecision Dose Recalls Ranitidine Oral Solution Due to NDMA Impurity
FDA (Drugs) · 2020-03-18
Same hazard · subpotent drug
See all →- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02